Find comprehensive information on Herpes Simplex Virus HSV diagnosis in pregnancy. This resource covers clinical documentation, medical coding, ICD-10 codes for HSV in pregnancy, neonatal herpes, and healthcare guidelines for managing HSV infections during pregnancy. Learn about HSV testing, treatment, and prevention strategies for pregnant women. Explore resources for healthcare professionals focusing on perinatal HSV transmission, antiviral therapy during pregnancy, and appropriate medical coding procedures.
Also known as
Herpes simplex virus infection in pregnancy
Herpes simplex virus (HSV) infection complicating pregnancy, childbirth and the puerperium.
Other specified maternal infections
Other specified maternal infections complicating pregnancy, childbirth and the puerperium.
Herpetic gingivostomatitis and pharyngotonsillitis
Infection of the mouth and throat caused by the herpes simplex virus.
Herpesviral infection, unspecified site
Herpes simplex virus infection, unspecified site, not otherwise specified.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is this a first episode of HSV in pregnancy?
When to use each related code
| Description |
|---|
| Herpes simplex in pregnancy |
| Varicella zoster in pregnancy |
| Cytomegalovirus in pregnancy |
Coding lacks specificity (e.g., genital vs. oral) impacting severity and management tracking. CDI should query for clarification.
Miscoded initial vs. recurrent infection affects risk assessment and treatment. Coding audits should verify accuracy.
Inaccurate maternal HSV coding may lead to missed neonatal HSV diagnosis and delayed antiviral treatment.
Q: How can I accurately diagnose herpes simplex virus (HSV) in a pregnant patient presenting with atypical or subclinical symptoms?
A: Diagnosing herpes simplex virus (HSV) in pregnant patients, especially with atypical or subclinical presentations, can be challenging. While viral culture remains the gold standard, its sensitivity can be limited. Polymerase chain reaction (PCR) testing of lesion swabs or cerebrospinal fluid offers higher sensitivity and is particularly useful in cases of suspected neonatal HSV or disseminated infection. Serologic testing for HSV IgG and IgM antibodies can help determine prior exposure, but its role in acute infection diagnosis during pregnancy is less clear. In cases of suspected genital herpes, consider obtaining type-specific serologic tests to differentiate between HSV-1 and HSV-2. For pregnant women with a history of HSV, close monitoring for recurrence during the third trimester is crucial. Explore how PCR testing can be integrated into your practice for improved HSV diagnosis in pregnancy. Consider implementing a standardized protocol for evaluating pregnant women with suspected HSV.
Q: What are the potential risks of neonatal herpes simplex virus (HSV) transmission during vaginal delivery and what preventative measures should be considered?
A: Neonatal herpes simplex virus (HSV) acquired during vaginal delivery can have devastating consequences, ranging from localized skin, eye, and mouth infections to disseminated disease involving multiple organs or central nervous system involvement. The risk of transmission is highest during primary HSV infection in the mother near the time of delivery. Women with recurrent HSV outbreaks have a significantly lower risk of neonatal transmission. Preventative measures include antiviral suppressive therapy from 36 weeks gestation until delivery for women with a history of genital herpes. Cesarean delivery is recommended for women with active genital lesions or prodromal symptoms at the time of labor. Learn more about the guidelines for antiviral prophylaxis and delivery management in pregnant women with HSV to minimize the risk of neonatal transmission. Consider implementing universal HSV screening discussions with pregnant patients to identify and manage those at risk.
Patient presents with suspected Herpes Simplex Virus (HSV) in pregnancy. Onset of symptoms, including prodrome of tingling, burning, or itching, began (date). Physical examination reveals (lesion description: location, size, morphology; e.g., multiple small vesicles on erythematous base on labia minora). Patient reports (symptoms: pain, dysuria, fever, malaise). Differential diagnosis includes herpes genitalis, varicella-zoster virus, syphilis, and other sexually transmitted infections (STIs). Diagnostic testing includes viral culture, polymerase chain reaction (PCR) testing, and serologic testing for HSV-1 and HSV-2 antibodies. Gestational age is (number) weeks. Risk assessment for neonatal herpes simplex is being conducted, considering factors such as primary versus recurrent infection, gestational age at onset, and mode of delivery. Treatment plan includes antiviral therapy with acyclovir, valacyclovir, or famciclovir to reduce viral shedding, alleviate symptoms, and potentially reduce the risk of transmission to the neonate. Patient education provided regarding antiviral medication management, safe sex practices, pain management, and the importance of follow-up care. Patient counseling includes discussion of risks and benefits of vaginal delivery versus cesarean section based on presence or absence of active lesions at the time of labor. Medical coding considerations include ICD-10 codes for herpes genitalis (A60.0-A60.9), pregnancy complications affecting the fetus or newborn (P00.0-P04.9), and encounter for antenatal screening (Z36.8). Billing codes for laboratory tests, antiviral prescriptions, and office visits are documented. Close monitoring of maternal and fetal well-being is warranted.